Works by Bonneterre, Jacques

Results: 33

CSF CA 15-3 in breast cancer-related leptomeningeal metastases.

Published in:

Journal of Neuro-Oncology, 2014, v. 117, n. 1, p. 117, doi. 10.1007/s11060-014-1361-1

By:

Le Rhun, Emilie;
Kramar, Andrew;
Salingue, Sophie;
Girot, Marie;
Rodrigues, Isabelle;
Mailliez, Audrey;
Zairi, Fahed;
Bakhache, Edgar;
Robin, Yves;
Taillibert, Sophie;
Dubois, François;
Bonneterre, Jacques;
Chamberlain, Marc

Publication type:

Article

Clinicopathological features of breast cancers predict the development of leptomeningeal metastases: a case-control study.

Published in:

Journal of Neuro-Oncology, 2011, v. 105, n. 2, p. 309, doi. 10.1007/s11060-011-0592-7

By:

Le Rhun, Emilie;
Taillibert, Sophie;
Zairi, Fahed;
Devos, Patrick;
Pierret, Matthieu;
Dubois, François;
Assaker, Richard;
Buisset, Etienne;
Bonneterre, Jacques;
Baranzelli, Marie

Publication type:

Article

Individual Life Expectancy Estimation Using Validated Prognostic Scores for Patients with Cancer of Unknown Primary.

Published in:

Oncology, 2010, v. 78, n. 2, p. 87, doi. 10.1159/000306137

By:

Ferté, Charles;
Penel, Nicolas;
Bonneterre, Jacques;
Adenis, Antoine

Publication type:

Article

Prolonged Response and Restoration of Functional Independence with Bevacizumab plus Vinorelbine as Third-Line Treatment for Breast Cancer-Related Leptomeningeal Metastases.

Published in:

Case Reports in Oncology, 2015, v. 8, n. 1, p. 72, doi. 10.1159/000375293

By:

Le Rhun, Emilie;
Taillibert, Sophie;
Boulanger, Thomas;
Zairi, Fahed;
Bonneterre, Jacques;
Chamberlain, Marc C.

Publication type:

Article

Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine.

Published in:

Case Reports in Oncology, 2014, v. 7, n. 2, p. 555, doi. 10.1159/000365747

By:

Mailliez, Audrey;
Servent, Véronique;
Bonneterre, Jacques;
Le Rhun, Emilie

Publication type:

Article

Dose-Seeking Phase I Trials for Currently Approved Molecular-Targeted Therapies in the USA: The Dose-Limiting Toxicity Definition Issue.

Published in:

Pharmaceutical Medicine, 2016, v. 30, n. 3, p. 143, doi. 10.1007/s40290-016-0138-6

By:

Kotecki, Nuria;
Awada, Ahmad;
Bonneterre, Jacques;
Hebbar, Mohamed;
Adenis, Antoine;
Cortot, Alexis;
Cousin, Sophie;
Clisant, Stéphanie;
Duhamel, Alain;
Penel, Nicolas

Publication type:

Article

Paclitaxel, Epirubicin and Cyclophosphamide Combination in First-Line Treatment of Metastatic Breast Cancer: A Dose Escalation Study.

Published in:

Oncology, 2004, v. 66, n. 3, p. 185, doi. 10.1159/000077993

By:

Bonneterre, Jacques;
Tubiana-Hulin, Michèle;
Catimel, Gilles

Publication type:

Article

A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy.

Published in:

Breast Cancer Research & Treatment, 2015, v. 152, n. 3, p. 569, doi. 10.1007/s10549-015-3493-1

By:

Le Rhun, Emilie;
Delbeuck, Xavier;
Lefeuvre-Plesse, Claudia;
Kramar, Andrew;
Skrobala, Emilie;
Pasquier, Florence;
Bonneterre, Jacques

Publication type:

Article

Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course.

Published in:

Breast Cancer Research & Treatment, 2012, v. 131, n. 2, p. 517, doi. 10.1007/s10549-011-1832-4

By:

Kolesnikov-Gauthier, Hélène;
Vanlemmens, Laurence;
Baranzelli, Marie-Christine;
Vennin, Philippe;
Servent, Véronique;
Fournier, Charles;
Carpentier, Philippe;
Bonneterre, Jacques

Publication type:

Article

Parvovirus H-1 induces cytopathic effects in breast carcinoma-derived cultures.

Published in:

Breast Cancer Research & Treatment, 2010, v. 121, n. 1, p. 23, doi. 10.1007/s10549-009-0451-9

By:

Muharram, Ghaffar;
Le Rhun, Emilie;
Loison, Ingrid;
Wizla, Pierre;
Richard, Audrey;
Martin, Nathalie;
Roussel, Annie;
Begue, Agnes;
Devos, Patrick;
Baranzelli, Marie-Christine;
Bonneterre, Jacques;
Caillet-Fauquet, Perrine;
Stehelin, Dominique

Publication type:

Article

Erratum: Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. Nicolas P, Yazdan Y, Marie-Pierre C, Stéphanie C, Sylvia G, Jean-Charles N, Danièle L, Charles F, Jacques B. 2007. J Surg Oncol 96:124-129.

Published in:

Journal of Surgical Oncology, 2008, v. 97, n. 5, p. 479, doi. 10.1002/jso.20943

By:

Penel, Nicolas;
Yazdanpanah, Yazdan;
Chauvet, Marie-Pierre;
Clisant, Stéphanie;
Giard, Sylvia;
Neu, Jean-Charles;
Lefebvre, Danièle;
Fournier, Charles;
Bonneterre, Jacques

Publication type:

Article

Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection.

Published in:

Journal of Surgical Oncology, 2007, v. 96, n. 2, p. 124, doi. 10.1002/jso.20796

By:

Nicolas, Penel;
Yazdan, Yazdanpanah;
Marie-Pierre, Chauvet;
Stéphanie, Clisant;
Sylvia, Giard;
Jean-Charles, Neu;
Danièle, Lefebvre;
Charles, Fournier;
Jacques, Bonneterre

Publication type:

Article

Relationships between progesterone receptor isoforms and the HER/ErbB receptors and ligands network in 299 primary breast cancers.

Published in:

International Journal of Biological Markers, 2012, v. 27, n. 2, p. 111, doi. 10.5301/JBM.2012.9198

By:

Lindet, Clothilde;
Révillion, Françoise;
Lhotellier, Valérie;
Hornez, Louis;
Peyrat, Jean-Philippe;
Bonneterre, Jacques

Publication type:

Article

Should a Multigene Signature be Used in all Luminal Early Breast Cancers.

Published in:

Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00454

By:

Hajjaji, Nawale;
Robin, Yves Marie;
Bonneterre, Jacques

Publication type:

Article

Securing the circuit of intrathecally administered cancer drugs: example of a collective approach.

Published in:

Journal of Oncology Pharmacy Practice, 2011, v. 17, n. 3, p. 252, doi. 10.1177/1078155210372550

By:

Marliot, Guillaume;
Le Rhun, Emilie;
Sakji, Ilyes;
Bonneterre, Jacques;
Cazin, Jean-Louis

Publication type:

Article

Predictors for establishing recommended phase 2 doses: analysis of 320 dose-seeking oncology phase 1 trials.

Published in:

Investigational New Drugs, 2012, v. 30, n. 2, p. 653, doi. 10.1007/s10637-010-9574-4

By:

Penel, Nicolas;
Duhamel, Alain;
Adenis, Antoine;
Devos, Patrick;
Isambert, Nicolas;
Clisant, Stéphanie;
Bonneterre, Jacques

Publication type:

Article

Nature and subjectivity of dose-limiting toxicities in contemporary phase 1 trials: comparison of cytotoxic versus non-cytotoxic drugs.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1414, doi. 10.1007/s10637-010-9490-7

By:

Penel, Nicolas;
Adenis, Antoine;
Clisant, Stéphanie;
Bonneterre, Jacques

Publication type:

Article

Justification of the starting dose as the main determinant of accrual time in dose-seeking oncology phase 1 trials.

Published in:

Investigational New Drugs, 2010, v. 28, n. 6, p. 839, doi. 10.1007/s10637-009-9317-6

By:

Penel, Nicolas;
Leblond, Pierre;
Lansiaux, Amélie;
Clisant, Stéphanie;
Dansin, Eric;
Adenis, Antoine;
Bonneterre, Jacques

Publication type:

Article

Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics.

Published in:

Investigational New Drugs, 2010, v. 28, n. 1, p. 76, doi. 10.1007/s10637-009-9224-x

By:

Penel, Nicolas;
Delord, Jean-Pierre;
Bonneterre, Marie-Edith;
Bachelot, Thomas;
Ray-Coquard, Isabelle;
Blay, Jean-Yves;
Pascal, Laurent;
Borel, Cécile;
Filleron, Thomas;
Adenis, Antoine;
Bonneterre, Jacques

Publication type:

Article

“Classical 3 + 3 design” versus “accelerated titration designs”: analysis of 270 phase 1 trials investigating anti-cancer agents.

Published in:

Investigational New Drugs, 2009, v. 27, n. 6, p. 552, doi. 10.1007/s10637-008-9213-5

By:

Penel, Nicolas;
Isambert, Nicolas;
Leblond, Pierre;
Ferte, Charles;
Duhamel, Alain;
Bonneterre, Jacques

Publication type:

Article

Prognostic factors among cancer patients with good performance status screened for phase I trials.

Published in:

Investigational New Drugs, 2008, v. 26, n. 1, p. 53

By:

Marie Vanseymortier;
Marie-Edith Bonneterre;
StÃ©phanie Clisant;
Eric Dansin;
Yvette Vendel;
RÃ©gis Beuscart;
Jacques Bonneterre

Publication type:

Article

The Quality of Life of Young Women with Nonmetastatic Breast Cancer and their Partners': Specific Needs Require Development of Specific Questionnaires for Each of them.

Published in:

Breast Journal, 2012, v. 18, n. 2, p. 182, doi. 10.1111/j.1524-4741.2011.01218.x

By:

Vanlemmens, Laurence;
Christophe, Véronique;
Fournier, Emmanuelle;
Dauchy, Sarah;
Boinon, Diane;
Toudic-Emily, Floriane;
Duffour, Betty;
Machavoine, Jean-Luc;
Reich, Michel;
Bonneterre, Jacques;
Domont, Julien;
Kaci, Fazia Aït;
Antoine, Pascal

Publication type:

Article

Is there a Reliable Method to Assess the Complete Pathologic Response on the Tumor after Neo-adjuvant Chemotherapy in Inflammatory Breast Cancer toward Recommendations for the Pathologic Process? Experience in 56 Patients Treated in a Single Institution.

Published in:

Breast Journal, 2010, v. 16, n. 5, p. 464, doi. 10.1111/j.1524-4741.2010.00957.x

By:

Mailliez, Audrey;
Baranzelli, Marie Christine;
Giard, Sylvia;
Ceugnart, Luc;
Vanlemmens, Laurence;
Belkacemi, Yazid;
Robin, Yves Marie;
Bonneterre, Jacques

Publication type:

Article

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.

Published in:

PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204973

By:

Cottu, Paul H.;
Bonneterre, Jacques;
Varga, Andrea;
Campone, Mario;
Leary, Alexandra;
Floquet, Anne;
Berton-Rigaud, Dominique;
Sablin, Marie-Paule;
Lesoin, Anne;
Rezai, Keyvan;
Lokiec, François M.;
Lhomme, Catherine;
Bosq, Jacques;
Bexon, Alice S.;
Gilles, Erard M.;
Proniuk, Stefan;
Dieras, Veronique;
Jackson, David M.;
Zukiwski, Alexander;
Italiano, Antoine

Publication type:

Article

High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer.

Published in:

Oncology Letters, 2016, v. 12, n. 2, p. 1422, doi. 10.3892/ol.2016.4791

By:

PANNIER, DIANE;
PHILIPPIN-LAURIDANT, GÉRALDINE;
BARANZELLI, MARIE-CHRISTINE;
BERTIN, DELPHINE;
BOGART, EMILIE;
DELPRAT, VICTOR;
VILLAIN, GAËLLE;
MATTOT, VIRGINIE;
BONNETERRE, JACQUES;
SONCIN, FABRICE

Publication type:

Article

Value of a gene signature assay in patients with early breast cancer and intermediate risk: a single institution retrospective study.

Published in:

2016

By:

Bonneterre, Jacques;
Prat, Aleix;
Galván, Patricia;
Morel, Pascale;
Giard, Sylvia;
Galván, Patricia

Publication type:

journal article

Decrease social inequalities return-to-work: development and design of a randomised controlled trial among women with breast cancer.

Published in:

BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-267

By:

Vidor, Clémence;
Leroyer, Ariane;
Christophe, Véronique;
Seillier, Mélanie;
Foncel, Jérome;
Van de Maële, Justine;
Bonneterre, Jacques;
Fantoni, Sophie

Publication type:

Article

Decrease social inequalities return-to-work: development and design of a randomised controlled trial among women with breast cancer.

Published in:

BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-267

By:

Vidor, Clémence;
Leroyer, Ariane;
Christophe, Véronique;
Seillier, Mélanie;
Foncel, Jérome;
Van de Maële, Justine;
Bonneterre, Jacques;
Fantoni, Sophie

Publication type:

Article

Decrease social inequalities return-to-work: development and design of a randomised controlled trial among women with breast cancer.

Published in:

2014

By:

Vidor, Clémence;
Leroyer, Ariane;
Christophe, Véronique;
Seillier, Mélanie;
Foncel, Jérome;
Van de Maële, Justine;
Bonneterre, Jacques;
Fantoni, Sophie

Publication type:

journal article

A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer.

Published in:

2019

By:

Macpherson, Iain R.;
Spiliopoulou, Pavlina;
Rafii, Saeed;
Saggese, Matilde;
Baird, Richard D.;
Garcia-Corbacho, Javier;
Italiano, Antoine;
Bonneterre, Jacques;
Campone, Mario;
Cresti, Nicola;
Posner, John;
Takeda, Yousuke;
Arimura, Akinori;
Spicer, James

Publication type:

journal article

Author reply.

Published in:

Cancer (0008543X), 2002, v. 95, n. 11, p. 2443, doi. 10.1002/cncr.10959

By:

Bonneterre, Jacques;
Buzdar, Aman;
Nabholtz, Jean-Marc;
Robertson, John;
Thürlimann, Beat;
von Euler, Mikael;
Sahmoud, Tarek;
Steinberg, Mark;
Webster, Alan

Publication type:

Article

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.

Published in:

2001

By:

Bonneterre, Jacques;
Buzdar, Aman;
Nabholtz, Jean-Marc A.;
Robertson, John F. R.;
Thürlimann, Bert;
von Euler, Mikael;
Sahmoud, Tarek;
Webster, Alan;
Steinberg, Mark;
Bonneterre, J;
Buzdar, A;
Nabholtz, J M;
Robertson, J F;
Thürlimann, B;
von Euler, M;
Sahmoud, T;
Webster, A;
Steinberg, M;
Arimidex Writing Committee;
Investigators Committee Members

Publication type:

journal article

Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis.

Published in:

BMC Clinical Pathology, 2012, v. 12, n. 1, p. 21, doi. 10.1186/1472-6890-12-21

By:

Le Rhun, Emilie;
Massin, Fr�d�ric;
Tu, Qian;
Bonneterre, Jacques;
De Carvalho Bittencourt, Marcelo;
Faure, Gilbert C.

Publication type:

Article